Business
ACT: Record 2024 results and robust 2025 outlook fueled by Specialty Chemicals growth
ACT: Record 2024 results and robust 2025 outlook fueled by Specialty Chemicals growth
About this update from Alzchem Group Ag
Alzchem Group delivered record sales and EBITDA in 2024, driven by Specialty Chemicals, with strong cash flow, a higher dividend, and a positive outlook for 2025. Investments in capacity and sustainability support future growth. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.